DCM
ACOR

Driehaus Capital Management’s Acorda Therapeutics ACOR Stock Holding History

Driehaus Capital Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-433
Closed -$1.76M – 616
2014
Q3 		$1.76M Buy
+433
New +$1.62M 0.07% 349

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Driehaus Capital Management's ACOR Position: Q4 2014 in Review

Driehaus Capital Management sold out of Acorda Therapeutics (ACOR) in Q4 2014, closing a stake of 433 shares — an estimated $1.76M sold.

Driehaus Capital Management first reported a position in ACOR in Q3 2014 and held it in 1 quarter. The position peaked at $1.76M in Q3 2014. 179 funds tracked by Wall St. Rank hold ACOR as of Q4 2014.

  • Driehaus Capital Management reported no remaining Acorda Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Driehaus Capital Management sold 433 Acorda Therapeutics shares in Q4 2014, an estimated $1.76M.
  • Driehaus Capital Management first reported a position in Acorda Therapeutics in Q3 2014 and held it in 1 quarter.
  • Driehaus Capital Management's Acorda Therapeutics position peaked at $1.76M in Q3 2014.
  • 179 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2014.

Based on Driehaus Capital Management's 13F filing for Q4 2014, filed 13 Feb 2015.